TB-500 for Dogs

📄 5 PubMed citations

TB-500 is the second half of the pet "wolverine stack." Here is the real mechanism, the tissue-repair evidence, and the honest fact that no canine study exists.

🔬 TB-500 is a synthetic fragment of thymosin beta-4. We cover the actual wound- and tendon-repair literature (rodent and in-vitro) and state plainly that there is no published study of TB-500 in dogs, rather than inventing a canine dose.

🧪 Buy TB-500 (Thymosin Beta-4) at Swiss Chems →

Code HIGHPEP10 — 10% off regular-priced items

Rat tendon study incl. TB-500

Canine TB-500 studies

Established canine doses

Senior black shepherd-type dog with a gray muzzle lying on its back on a wooden deck — Photo: W J (Bill) Harrison · CC BY · source

Mechanism of Action

How It Works

🩸

Actin-sequestering repair protein

Thymosin beta-4 (the parent of TB-500) binds actin and supports cell migration, angiogenesis and wound repair across tissues (PMID 16099219). TB-500 is its synthetic active fragment.

🔥

Inflammation & tendon

TB4 limits inflammation via autophagy (PMID 30063848) and has been engineered into tendon-repair scaffolds (PMID 31753373). A 2026 rat Achilles study found TB-500 significantly improved tendon architecture (PMID 42542926).

🐕

The canine unknown

None of this was done in dogs. A PubMed search for "TB-500 dog" and "thymosin beta 4 canine" returns zero results (2026). There is no canine efficacy, safety, or dosing data.

Data

What the Data Shows

TB4/TB-500 repair & inflammation studies

rodent + in-vitro

Multiple

Rat tendon study incl. TB-500

PMID 42542926

Canine TB-500 studies

PubMed, 2026

Protocol

Daily Dosing Schedule

Time	Compounds
Rat Achilles study (Biçer 2026)	TB-500 60 µg/kg/day, intraperitoneal, 4 weeks — rat-model dose (PMID 42542926), not a dog protocol

⚠️ There is no published canine dose for TB-500. The single row above is a rat study dose, shown for reference only, and must not be scaled to a dog. The most-shared owner dog protocol used BPC-157, not TB-500.

Bottom Line

Key Takeaways

✅ What We Know

TB-500 is a synthetic fragment of thymosin beta-4, an actin-binding tissue-repair protein (PMID 16099219).
TB4/TB-500 supports wound repair and dampens inflammation in rodent and in-vitro models (PMID 30063848, 26096726).
A 2026 rat Achilles study found TB-500 significantly improved tendon architecture (PMID 42542926).
It is the second component of the widely searched BPC-157 + TB-500 stack.

⚠️ What We Don't Know

No study of TB-500 in dogs has been published (PubMed: 0 results, 2026).
There is no established or veterinary canine dose; the rat dose is not a protocol.
Canine safety and long-term effects are entirely unstudied.
The viral owner anecdotes involved BPC-157, not TB-500, so even anecdotal TB-500 dog data is scarce.

FAQ

Frequently Asked Questions

Is TB-500 safe for dogs?

Unknown. There is no published safety or toxicology study of TB-500 in dogs. Everything known about TB-500/thymosin beta-4 comes from rodents and cell studies. Treat canine safety as unestablished and consult a veterinarian.

What is a TB-500 dose for dogs?

There isn’t an established one. No canine study has set a dose. A 2026 rat study used 60 µg/kg/day intraperitoneally (PMID 42542926), but that is a lab dose in rats, not a recommendation for dogs.

How is TB-500 different from BPC-157?

BPC-157 is a stomach-derived pentadecapeptide studied mostly for tendon, ligament and gut healing; TB-500 is a thymosin beta-4 fragment studied for actin-driven cell migration and wound repair. See our BPC-157 vs TB-500 comparison.

🧪 Buy TB-500 (Thymosin Beta-4) — Research Grade

Swiss Chems publishes third-party HPLC COAs for selected products — vendor-published, a claim to verify. Deep-linked to the TB-500 (Thymosin Beta-4) product page.

Buy TB-500 (Thymosin Beta-4) at Swiss Chems →

Code HIGHPEP10 — 10% off regular-priced items

Affiliate links — support HighPeptides at no extra cost.